Diabetes Mellitus, Type 1
Showing NaN - NaN of 42
Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 1
- Empagliflozin
- Placebo
-
Montgomery, Alabama
- +188 more
Oct 31, 2018
Celiac Disease, Diabetes, Type 1 Trial in Canada (Gluten Free Diet)
Completed
- Celiac Disease
- Diabetes Mellitus, Type 1
- Gluten Free Diet
-
Hamilton, Ontario, Canada
- +6 more
Sep 4, 2018
Diabetes, Type 1 Trial in Worldwide (otelixizumab infusion plus physician determined standard of care, infusion plus physician
Completed
- Diabetes Mellitus, Type 1
- otelixizumab infusion plus physician determined standard of care
- placebo infusion plus physician determined standard of care
-
Birmingham, Alabama
- +108 more
Sep 5, 2017
Diabetes, Type 1 Trial in Worldwide (Insulin detemir, NPH insulin)
Completed
- Diabetes Mellitus, Type 1
- Insulin detemir
- NPH insulin
-
Broadmeadow, New South Wales, Australia
- +92 more
Jul 17, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Duarte, California
- +15 more
Feb 28, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, NPH insulin, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin detemir
- +2 more
-
Buenos Aires, Argentina
- +99 more
Jan 30, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Little Rock, Arkansas
- +181 more
Jan 16, 2017
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Cambridge, Leeds, London (Overnight closed-loop, Real-time CGM
Completed
- Diabetes Mellitus
- +4 more
- Overnight closed-loop
- Real-time CGM alone
-
Cambridge, United Kingdom
- +2 more
Feb 28, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin aspart, human soluble insulin, insulin NPH)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin aspart
- +2 more
-
Graz, Austria
- +79 more
Jan 3, 2017
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart 50, biphasic insulin aspart 70,
Completed
- Diabetes
- +2 more
- biphasic insulin aspart 50
- +2 more
-
Aalst, Belgium
- +76 more
Jan 3, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (human insulin, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- human insulin
- insulin aspart
-
Ciudad de Buenos Aires, Argentina
- +94 more
Dec 20, 2016
Safety of LevemirĀ® in Patients With Diabetes
Completed
- Diabetes
- +2 more
- insulin detemir
-
Dublin, Ireland
- +1 more
Oct 27, 2016
Diabetes, Type 1 Trial in Canada, United States (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)
Completed
- Diabetes Mellitus, Type 1
- Canagliflozin 100 mg
- +2 more
-
Little Rock, Arkansas
- +52 more
Jun 7, 2016
Diabetes, Type 1, Diabetes, Type 2, Asthma Trial in Worldwide (Technosphere Insulin)
Terminated
- Diabetes Mellitus, Type 1
- +2 more
- Technosphere Insulin
-
Phoenix, Arizona
- +77 more
May 3, 2012
Diabetes, Type 1 Trial in United Kingdom (X54 insulin pump with low suspend feature)
Completed
- Diabetes Mellitus, Type 1
- X54 insulin pump with low suspend feature
-
Cambridge, Cambridgeshire, United Kingdom
- +5 more
Feb 16, 2011
Diabetes, Type 1 Trial in Worldwide (Subcutaneous Insulin, Inhaled Insulin)
Terminated
- Diabetes Mellitus, Type 1
- Subcutaneous Insulin
- Inhaled Insulin
-
Fullerton, California
- +72 more
Feb 3, 2010
Diabetes, Type 1 Trial in Canada, United States (Inhaled human insulin)
Completed
- Diabetes Mellitus, Type 1
- Inhaled human insulin
-
Burlingame, California
- +36 more
Feb 9, 2007